TY  - GEN
AU  - van Schaik,Ron H N
AU  - Kok,Marleen
AU  - Sweep,Fred C G J
AU  - van Vliet,Martin
AU  - van Fessem,Marianne
AU  - Meijer-van Gelder,Marion E
AU  - Seynaeve,Caroline
AU  - Lindemans,Jan
AU  - Wesseling,Jelle
AU  - Van 't Veer,Laura J
AU  - Span,Paul N
AU  - van Laarhoven,Hanneke
AU  - Sleijfer,Stefan
AU  - Foekens,John A
AU  - Linn,Sabine C
AU  - Berns,Els M J J
TI  - The CYP2C19*2 genotype predicts tamoxifen treatment outcome in advanced breast cancer patients
SN  - 1744-8042
PY  - 2011///1102
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents, Hormonal
KW  - therapeutic use
KW  - Aryl Hydrocarbon Hydroxylases
KW  - genetics
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Combined Modality Therapy
KW  - Cytochrome P-450 CYP2C19
KW  - Cytochrome P-450 CYP2D6
KW  - DNA, Neoplasm
KW  - Data Interpretation, Statistical
KW  - Female
KW  - Follow-Up Studies
KW  - Genotype
KW  - Humans
KW  - Lymphatic Metastasis
KW  - pathology
KW  - Menopause
KW  - Middle Aged
KW  - Pharmacogenetics
KW  - Predictive Value of Tests
KW  - Prognosis
KW  - Receptors, Progesterone
KW  - metabolism
KW  - Retrospective Studies
KW  - Survival Analysis
KW  - Tamoxifen
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.2217/pgs.11.54
ER  -